Next Article in Journal
Development of a Silicone-Based Polymer Matrix as a Suitable Transdermal Therapeutic System for Diallyl Disulfide
Previous Article in Journal
Immunomodulatory Effect of Polysaccharides from the Mushroom-Forming Basidiomycete Gymnopilus imperialis (Agaricomycetes, Basidiomycota)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study

by
Mahmoud A. A. Ibrahim
1,2,*,
Al-shimaa S. M. Rady
1,
Asmaa M. A. Mandarawe
1,
Lamiaa A. Mohamed
1,
Ahmed M. Shawky
3,
Tamer H. A. Hasanin
4,
Peter A. Sidhom
5,
Mahmoud E. S. Soliman
6 and
Nayra A. M. Moussa
1
1
Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt
2
School of Health Sciences, University of Kwa-Zulu-Natal, Westville, Durban 4000, South Africa
3
Science and Technology Unit (STU), Umm Al-Qura University, Makkah 21955, Saudi Arabia
4
Department of Chemistry, College of Science, Jouf University, Sakaka P.O. Box 2014, Saudi Arabia
5
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt
6
Molecular Bio-Computation and Drug Design Research Laboratory, School of Health Sciences, University of Kwa-Zulu-Natal, Westville, Durban 4000, South Africa
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(10), 1181; https://doi.org/10.3390/ph15101181
Submission received: 11 September 2022 / Revised: 18 September 2022 / Accepted: 19 September 2022 / Published: 23 September 2022
(This article belongs to the Section Pharmaceutical Technology)

Abstract

:
The efficacy of pure and aluminum (Al)-doped boron nitride nanocarriers (B12N12 and AlB11N12) in adsorbing Chlormethine (CM), an anti-cancer drug, was comparatively dissected by means of the density functional theory method. The CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes were studied within two configurations, A and B, in which the adsorption process occurred via N∙∙∙ and Cl∙∙∙B/Al interactions, respectively. The electrostatic potential affirmations confirmed the opulent ability of the studied nanocarriers to engage in delivering CM via two prominent electrophilic sites (B and Al). Furthermore, the adsorption process within the CM∙∙∙AlB11N12 complexes was noticed to be more favorable compared to that within the CM∙∙∙B12N12 analog and showed interaction and adsorption energy values up to –59.68 and −52.40 kcal/mol, respectively, for configuration A. Symmetry-adapted perturbation theory results indicated that electrostatic forces were dominant in the adsorption process. Notably, the adsorption of CM over B12N12 and AlB11N12 nanocarriers exhibited predominant changes in their electronic properties. An elemental alteration was also revealed for the softness and hardness of B12N12 and AlB11N12 nanocarriers before and following the CM adsorption. Spontaneity and exothermic nature were obviously observed for the studied complexes and confirmed by the negative values of thermodynamic parameters. In line with energetic manifestation, Gibbs free energy and enthalpy change were drastically increased by the Al doping process, with values raised to –37.15 and –50.14 kcal/mol, respectively, for configuration A of the CM∙∙∙AlB11N12 complex. Conspicuous enhancement was noticed for the adsorption process in the water phase more than that in the gas phase and confirmed by the negative values of the solvation energy up to −53.50 kcal/mol for configuration A of the CM∙∙∙AlB11N12 complex. The obtained outcomes would be the linchpin for the future utilization of boron nitride as a nanocarrier.

Graphical Abstract

1. Introduction

Owing to the tremendous blossoming of nanoscience in recent years, nanomaterials have been considered as potential candidates in a large array of applications such as optical devices [1], catalysis [2], and sensing materials [3]. Among the growing applications of nanomaterials, nanocarriers are of keen interest given their pivotal importance in the drug delivery process [4,5]. In the extending field of nanocarriers, fullerene-like structures were proved as potent drug nanocarriers, inspired by high biocompatibility and low cytotoxicity nature [6,7,8]. In the literature, group III nitride nanocarriers were found with exceptional properties, including elevated chemical stability, favorable band gap, suitable dielectric constant, considerable thermal conductivity, and upright oxidation resistance [9,10].
Furthermore, different geometries of boron nitrides (BxNx, where x refers to the number of boron and nitrogen atoms) were studied by Toftlund and Jensen, and the high stability of the B12N12 nanocarrier was addressed [11]. Soltani et al. confirmed that B12N12 was more preferable than B16N16 in the drug delivery process of a 5-aminolevulinic acid (5-AVA) drug [12]. By an arc-melting method, B12N12 was first synthesized with a band gap of 5.1 eV [13,14]. Afterward, B12N12 was extensively investigated to serve as a nanocarrier of diverse anti-cancer drugs such as Isoniazid [6], Amphetamine [15], Lomustine [16], etc. Consequently, the optical, electronic, and chemical features of the boron nitride (B12N12) nanocarrier were thoroughly under study. It was reported that a significant alteration in boron nitride features occurred through doping the B12N12 surface [17]. Concurrently, the aluminum (Al) atom is considered one of the most appropriate doping candidates due to its high porosity and ample surface active sites [18]. In fact, Al-doped boron nitride (AlB11N12) was reported as an excellent nanocarrier for several drugs, owing to the sharp changes in the band gap and the reversibility of the adsorption process [19]. In parallel, the AlB11N12 nanocarrier had a massive increment in its adsorption tendency, which was previously interpreted as an advantage of the Al doping processs [20,21]. Moreover, the adsorption processes of 5-aminosalicylic acid and the Cisplatin anti-cancer drug over the exterior surface of pristine and Al-doped B12N12 nanocarriers were investigated based on DFT calculations [22,23].
Chlormethine (CM), an anti-cancer drug with C5H11Cl2N chemical formula, was synthesized in 1935 and applied for cancer treatment in 1946. Pharmacologists proved the effectiveness of CM to treat prostate cancer, polycythemia vera, chronic myelocytic leukemia, and lymphosarcoma after clinical trials. Moreover, the topical formulation of CM was documented to be operative for different conditions such as skin diseases and cell lymphoma [24,25,26]. Nevertheless, CM had severe adverse effects that would eventually develop tentative blindness and skin cancer. With the aim of reducing undesirable side effects, versatile studies were conducted for using nanocarriers in the delivery process of CM. Subsequently, the adsorption process of CM over C24, B12C6N6, and B12N12 nanocarriers was investigated, revealing the crucial favorability for the B12N12 nanocarrier [27]. Moreover, the effect of transition metal-doped boron nitride was theoretically studied over the surfaces of the B12N12, ZnB12N12, NiB12N12, CoB12N12, FeB12N12, and CuB12N12 nanocarriers [28].
In the current investigation, the predilection of pure and Al-doped boron nitride nanocarriers (B12N12 and AlB11N12) to adsorb CM anti-cancer drug within configurations A and B was discussed (Figure 1). By means of density functional theory (DFT) calculations, the occurrences of the adsorption process within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes were detected in both gas and water phases. A series of thermodynamic parameters were also computed to elucidate the spontaneity and nature of the adsorption process. The obtained findings would be essential for the development of the applications of pure and doped boron nitride nanocarriers in the drug delivery process of anti-cancer drugs.

2. Results

2.1. Electrostatic Potential (ESP) Analysis

Electrostatic potential (ESP) analysis has been introduced as a convenient and useful tool to qualitatively and quantitatively identify chemical systems [29]. For the optimized systems, molecular electrostatic potential (MEP) maps were generated using 0.002 au electron density envelopes according to the previous recommendations [30]. From a numerical point of view, surface electrostatic potential extrema were calculated in terms of maximum (Vs,max) and minimum (Vs,min) electrostatic potential values. The optimized structures with corresponding MEP maps of Chlormethine (CM) and pure and aluminum (Al)-doped boron nitride nanocarriers (B12N12 and AlB11N12) are graphed in Figure 2.
As delineated in Figure 2, the B12N12 nanocarrier with Th symmetry was incorporated of identical eight hexagonal rings and six tetragonal rings. In terms of bond length, two nonequivalent B-N bond lengths were observed for the B12N12 nanocarrier: one between two hexagonal rings and the other one between a hexagonal and tetragonal ring. The B-N bond length was observed at 1.44 Å between two hexagonal rings and 1.48 Å between a hexagonal and tetragonal ring. Interestingly, the obtained bond length values were concomitant with previous studies [31,32].
For the AlB11N12 nanocarrier with the Cs point group, the Al-N bond between two hexagonal rings was noticed with a length of 1.78 Å, while the Al-N bond between tetragonal and hexagonal was 1.82 Å. The bond length values illustrated in Figure 2 were found to be compatible with previous studies pertinent to the influence of Al doping on the configuration of the B12N12 nanocarrier [22].
From MEP maps visualized in Figure 2, two nucleophilic sites labeled with red regions were noticed along the surface of the CM drug, numerically ensured by Vs,min values of –15.7 and –21.4 kcal/mol along the surface of the Cl and N atoms, respectively. Turning to nanocarriers, positive ESP regions were observed over B and Al atoms, indicating the electrophilic nature of nanocarriers (Figure 2). Illustratively, Vs,max values over B and Al atoms of B12N12 and AlB11N12 nanocarriers were 50.7 and 158.9 kcal/mol, respectively. Evidently, the negative ESP on the N atoms in the AlB11N12 system was found with a higher Vs,min value compared with that in the B12N12 system, ensuring the prominent electron donation ability of the Al atom more than the B atom. Quantitatively, Vs,min values of N atoms were –16.8 and –20.2 kcal/mol for the B12N12 and AlB11N12 nanocarriers, respectively.

2.2. Adsorption Process

The potentiality of pure and Al-doped boron nitride (B12N12 and AlB11N12) nanocarriers to adsorb the Chlormethine (CM) anti-cancer drug was thoroughly studied within configurations A and B for CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes (Figure 1). Geometrical optimization and MEP maps calculations were executed for the studied CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes, and the obtained structures are depicted in Figure 3. Table 1 compiles the interaction and adsorption energies of the optimized complexes along with intermolecular distances between the interacted species.
From the data listed in Table 1, substantial negative adsorption (Eads) and interaction (Eint) energies of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes were observed, ensuring the occurrence of the adsorption process within modeled configurations. Notably, short CM∙∙∙B/∙∙∙Al intermolecular distances within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes were detected, with values ranging from 1.64 Å to 2.82 Å (Figure 3 and Table 1).
Among the studied complexes, the CM∙∙∙AlB11N12 complex had higher negative interaction and adsorption energies compared with CM∙∙∙B12N12 complex and showed values of –59.68 and –52.40 kcal/mol, respectively, within configuration A. The favorability of CM∙∙∙AlB11N12 complex could be ascribed to the further prominent electrophilic character of the AlB11N12 nanocarrier compared with the B12N12 analog in line with the Vs,max affirmations, which showed values of 158.9 and 50.7 kcal/mol, respectively. The interpretation of the superior adsorption behavior of the AlB11N12 nanocarrier toward the CM drug via site A more than B could be considered as a consequence of the higher negativity of ESP over the N atom compared with the Cl one that showed Vs,min values of –21.4 and –15.7 kcal/mol, respectively. The obtained results were quite similar in their foundations to the literature, which documented the highest adsorption favorability through the N site of the CM drug over X3O (X = Li, Na, and K)-doped B12N12 nanocarriers [33]. It is worth mentioning that the presented result of the CM∙∙∙B12N12 complex within configuration A is compatible with a previous study [27]. It was reported that the B12N12 nanocarrier showed preferable potency toward adsorbing the CM drug with Eads up to −24.33 kcal/mol. The energy difference between the obtained and previously reported Eads values could be mainly relevant to the variant in the utilized levels of computations.

2.3. SAPT Calculations

Symmetry-adapted perturbation theory (SAPT) analysis was conducted to decompose the interaction energy into its four main physical forces, namely, electrostatic (Eelst), exchange (Eexch), dispersion (Edisp), and induction (Eind) forces. For the optimized complexes, SAPT analysis was performed at the SAPT0 level of theory applying PSI4 code [34]. The four physical components of the interaction energy of Chlormethine with B12N12 and AlB11N12 nanocarriers are graphically correlated in Figure 4.
It can be observed from Figure 4 that the electrostatic forces (Eelst) governed the adsorption process within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes. Notably, the dispersion (Edis) and induction (Eind) forces exhibited preferable contributions, reinforcing the occurrence of the adsorption process. On the other hand, exchange forces (Eexch) were found with positive values, demonstrating their unfavorable contribution to the forces beyond the adsorption process. Illustratively, the energetic values of Eelst, Eind, Edisp, and Eexch were found to be –87.09, –28.01, –19.43, and 81.69 kcal/mol, respectively, for the CM∙∙∙AlB11N12 complex within configuration A. Apparently, the obtained total SAPT0 energies were observed to be in line with the adsorption and interaction energy values (Table 1). Numerically, the total SAPT0 energies of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configurations A/B were –45.46/–7.91 and –59.74/–32.74 kcal/mol, respectively.
Although the Eelst and Eexch components of the CM∙∙∙B12N12 complex within configuration A showed higher values compared with that of the CM∙∙∙AlB11N12 complex, the total SAPT0 energy of the latter was higher than the former. Although the total SAPT0 energy of the CM∙∙∙AlB11N12 complex within configuration A was higher than that of the CM∙∙∙B12N12 analog, the Eelst and Eexch components of the latter complex showed higher values compared with those of the former.
Although the Eelst components of the CM∙∙∙B12N12 complex within configuration A showed a higher negative value compared with that of the CM∙∙∙AlB11N12 complex, the total SAPT0 energy of the latter complex was higher than the former. This observation could be interpreted by considering the Eexch component, which exhibited a higher positive value for the latter complex than the former. Illustratively, Eelst values were –116.28 and –87.09 kcal/mol for the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes, respectively, within configuration A. In contrast, Eexch values for CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configuration A were found to be 157.93 and 81.69 kcal/mol, respectively.

2.4. QTAIM and NCI Calculations

Quantum theory of atoms in molecules (QTAIM) and noncovalent interaction (NCI) index analyses were considered as informative investigations for visualizing inter- and intra-molecular interactions [35]. Upon QTAIM and NCI, the adsorption of a drug over nanocarriers was endorsed by electron density and its derivatives. By applying QTAIM analysis, bond paths (BPs) and bond critical points (BCPs) were generated. The topological derivatives, inclusive total energy density (Hb), Laplacian (∇2ρb), electron density (ρb), kinetic electron density (Gb), local potential electron energy density (Vb), and negative ratio of kinetic and potential electron energy density (−Gb/Vb) were calculated and are gathered in Table 2. Three-dimensional isosurface graphs were generated using sign (λ2)ρ with colors ranging from blue (–0.035 au) to red (0.020 au). QTAIM and 3D NCI diagrams of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes are depicted in Figure 5.
As explicitly shown in Figure 5, the tendency of B12N12 and AlB11N12 nanocarriers to adsorb the CM drug was clearly confirmed by the visualized bond critical points (BCPs) and bond paths (BPs) between the interacted species (i.e., N/Cl of CM drug and B/Al of B12N12/AlB11N12 nanocarriers). Evidently, the contributions of secondary interactions that supported the adsorption process within the studied complexes were noticed via the existence of variant BCPs and BPs between the hydrogen atom of the CM drug and the N atom of B12N12/AlB11N12 nanocarriers (Figure 5).
According to the data in Table 2, the partial covalent and electrostatic nature of the adsorption process within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes were generally unveiled. The obtained negative Hb values, positive ∇2ρb values, and values less than the unity of –Gb/Vb outlined the partial covalent and electrostatic nature of the interactions within the CM∙∙∙B12N12 (configuration A) and ∙∙∙AlB11N12 (configurations A and B) complexes [36]. For instance, Hb, ∇2ρb, and –Gb/Vb of the CM∙∙∙AlB11N12 complex within configuration A were –0.0046, 0.3581, and 0.9530 au, respectively. The CM∙∙∙B12N12 within configuration B was noticed with a weak electrostatic nature that was detected by the positive Hb values, positive ∇2ρb values, and values exceeding the unity for –Gb/Vb. Numerically, Hb, ∇2ρb, and –Gb/Vb of the CM∙∙∙B12N12 complex within configuration B were 0.0007, 0.0387, and 1.0842 au, respectively.
On 3D NCI isosurfaces, the tendency of the B12N12 and AlB11N12 nanocarriers to adsorb the CM dug was elucidated by the occurrence of colored isosurfaces between the interacted species within the studied complexes. Moreover, the change in the color scale of the 3D NCI isosurfaces was found to be concurrent with the adsorption energy pattern; the strongest and weakest interactions were observed in blue and green colors, respectively.

2.5. Electronic Parameters

The impact of the adsorption process of Chlormethine (CM) over pure and Al-doped boron nitride (B12N12 and AlB11N12) nanocarriers was investigated by elucidating their densities and electronic energy levels. To this end, the highest occupied molecular orbital (EHOMO), Fermi level (EFL), and the lowest unoccupied molecular orbital (ELUMO), were calculated before and after the adsorption process. Subsequently, the energy gap (Egap) was computed as the difference between the ELUMO and EHOMO. Figure 6 and Figure 7 show the electron densities of HOMO/LUMO for the isolated systems and complexes, respectively. The obtained EHOMO, EFL, ELUMO, and Egap values are given in Table 3.
As exemplified in Figure 6, the distributions of HOMO and LUMO represented the densities purely around the nucleophilic and electrophilic sites, respectively. Apparently, HOMO distributions were concentrated around the N and Cl atoms of the CM, while the LUMO ones were denoted over B and Al atoms of B12N12 and AlB11N12, respectively. Upon contact with CM, obvious changes in HOMO and LUMO distributions were identified, as is apparent in Figure 7. HOMO and LUMO levels were found over nanocarrier and drug, respectively, within the studied complexes, with an exception for the CM∙∙∙B12N12 complex within configuration B. This observation outlined that the occurrence of the adsorption process is attributed to the charge transfer between drug and nanocarriers in all the studied complexes. The HOMO and LUMO affirmations were consistent with the energetic ones summarized in Table 1, which highlighted the lesser favorability of the CM∙∙∙B12N12 complex within configuration B compared with other studied complexes.
According to the data in Table 3, the EHOMO, EFL, ELUMO, and Egap values of the pure B12N12 nanocarrier were evidently changed after doping by an Al atom in the AlB11N12 nanocarrier. From Table 3, the EHOMO, EFL, ELUMO, and Egap values of B12N12/AlB11N12 nanocarriers were –9.54/–9.10, –5.12/–7.05, –0.35/–2.50, and 9.19/6.60 eV, respectively. These numerical values particularly addressed the contributions of Al doping in destabilizing and stabilizing EHOMO and ELUMO of the pure B12N12 nanocarrier.
It is also worth mentioning that an obvious variation in EHOMO and ELUMO values was unveiled after the adsorption process of the CM drug over the B12N12 and AlB11N12 nanocarriers. Notably, a slight decline in EHOMO and EFL values was found after the adsorption process. For instance, EHOMO of B12N12 nanocarrier was –9.54 eV, and it diminished to –8.92 and –8.30 eV for CM∙∙∙B12N12 complexes within configurations A and B, respectively. Generally, obvious downshifts and upshifts in the ELUMO/Egap values were observed after the adsorption process within CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes, respectively.

2.6. Global Indices of Reactivity

Global indices of reactivity were computed before and after the adsorption process to comprehensively clarify the impact of adsorption of the CM drug over B12N12 and AlB11N12 nanocarriers. Various parameters, including ionization potential (IP), electron affinity (EA), chemical potential (μ), global hardness (η), global softness (S), electrophilicity index (ω), and work function (Φ), were calculated and are compiled in Table 4.
With regard to global indices of reactivity, a significant difference was denoted in the values of IP, EA, μ, η, S, ω, and Φ between the pure and Al-doped boron nitride (B12N12 and AlB11N12) nanocarriers. From summarized data in Table 4, the IP, EA, μ, η, S, ω, and Φ values of B12N12/AlB11N12 were 9.54/9.10 eV, 0.35/2.50 eV, –4.94/–5.80 eV, 4.60/3.30 eV, 0.22/0.30 eV–1, 2.66/5.10 eV, and 5.12/7.05 eV, respectively. Consequently, the Al doping enhanced the properties of the pure boron nitride nanocarrier to be a suitable surface for adsorbing the CM drug by declining and increasing the values of IP/η and EA/μ/S/ω/Φ, respectively.
Moreover, Table 4 offers insight into the substantial effect of the adsorption process of the CM drug over pure and Al-doped boron nitride (B12N12 and AlB11N12) nanocarriers via sizeable changes in the calculated reactivity parameters. As detailed in Table 4, IP values of the B12N12 and AlB11N12 nanocarriers decreased upon contact with the CM drug from 9.54 and 9.10 eV to 8.92 and 8.55 eV, respectively, within configuration A. The same pattern was noticed in the case of μ, ω, and Φ, and an irregular pattern was noticed for EA, η, and S values, which could be ascribed to the main dependence of these values on ELUMO. Overall, the noticeable difference in the global indices of reactivity parameters extensively ensured the adequacy of the B12N12 and AlB11N12 nanocarriers for adsorbing the CM drug, along with highlighting the preferential role of the Al doping process.

2.7. DOS Analysis

The density of states (DOS) analysis was apprehended for B12N12 and AlB11N12 nanocarriers before and after the adsorption process of the CM drug over B12N12 and AlB11N12 nanocarriers. DOS diagrams were generated and are expressed in Figure 8.
As is evident in Figure 8, the energy states within the DOS diagram of the AlB11N12 nanocarrier were found to be more concentrated than the B12N12 analog, revealing the favorable impact of the Al doping process on the electronic properties of the pure boron nitride (B12N12) nanocarrier.
It is apparent that the occurrence of the adsorption process within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes was thoroughly confirmed by the appearance of new energy states around the Fermi level in the extracted DOS diagrams. The resulted states were noticed more obviously in the case of CM∙∙∙AlB11N12 complexes compared with CM∙∙∙B12N12, in line with energetic patterns. Indeed, an obvious decrement in Egap was noticed following the adsorption of CM that in turn enhanced the conductivity (Equation (17)) of the investigated nanocarriers. Overall, the obtained results affirmed that the B12N12 and AlB11N12 nanocarriers are promising electrochemical biosensors for the Chlormethine (CM) anti-cancer drug.

2.8. Solvent Effect

Toward tackling the influence of the solvent on the adsorption process of the CM drug over B12N12 and AlB11N12 nanocarriers, the polarizable continuum model was utilized for water as a solvent. For the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes, the calculations of geometrical optimization were executed in the presence of water. Then, adsorption ( E ads solvent ) and solvation (ΔEsolv) energies were computed for the obtained optimized complexes and are given in Table 5.
According to summarized data in Table 5, negative values of E ads solvent were noticed for all the considered complexes, clarifying the potential of the B12N12 and AlB11N12 nanocarriers to adsorb CM in the water phase. In line with the data in Table 1, the energetics of the studied complexes in the water phase within configuration A were more preferable compared to B. For example, E ads solvent values of the CM∙∙∙B12N12 complex within configurations A and B were –30.86 and –4.06 kcal/mol, respectively.
Furthermore, the CM∙∙∙AlB11N12 complexes were noticed with higher negative values of E ads solvent   compared with CM∙∙∙B12N12 analogs. This observation consistently ensured the favorable Al doping contributions to the adsorption process in the water phase, as Table 5 shows. For instance, the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configuration A exhibited E ads solvent with values of –30.86 and –51.30 kcal/mol, respectively. Further favorability of the occurrence of the adsorption process was affirmed in the water phase more than in the gas phase and confirmed by the negative values of the ΔEsolv.

2.9. Thermodynamic Parameters

To deeply understand the nature of the adsorption process of the CM drug on the B12N12 and AlB11N12 nanocarriers, the thermodynamic parameters were computed. The thermodynamic parameters for CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes, at 1 atm and 298 K, Gibbs free energy (ΔG), enthalpy change (ΔH), and entropy change (ΔS) were calculated and are given in Table 6.
As shown in Table 6, the spontaneity of the adsorption process within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes was confirmed via the negative values of ΔG. Furthermore, negative ΔH values were an indication of the exothermic nature of the adsorption process within all considered complexes. Small and neglectable values of ΔS were noticed for all the studied complexes. Similar to the adsorption energy pattern, higher negative values of thermodynamic energetic quantities were mainly pertinent to the CM∙∙∙AlB11N12 complexes, compared with CM∙∙∙B12N12 complexes. From enrolled data in Table 6, the ΔG, ΔH, and ΔS of the CM∙∙∙AlB11N12 complexes within configuration A were –37.15, –50.14, and –0.04 kcal/mol, respectively.

2.10. Recovery Time

Recovery time (τ) is informative in the desorption process and is mainly correlated with the adsorption energy. For the CM∙∙∙B12N12 complexes within configurations A and B, τ values were 0.02 nS and 0.01 pS, respectively. In comparison, τ values of the CM∙∙∙AlB11N12 complexes within configurations A and B were 1.4 × 108 S and 0.11 μS, respectively. Apparently, the CM∙∙∙B12N12 complex within configuration B, the least favorable energetic complex, had the shortest recovery time value, indicating its preferential feasibility in the desorption process. Contrarily, the most favorable CM∙∙∙AlB11N12 complex within configuration A had the longest recovery time, which is consistent with its substantial negative adsorption energy. Based on these results, the B12N12 and AlB11N12 nanocarriers would be preferential for adsorbing the CM drug within the modeled configurations given their short recovery time.

3. Computational Methods

The adsorption process of the Chlormethine (CM) anti-cancer drug over the exterior surface of pure and aluminum (Al)-doped boron nitride nanocarriers (B12N12 and AlB11N12) was comparatively scrutinized. The CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes were modeled within configurations A and B, in which the adsorption process occurred via N∙∙∙ and Cl∙∙∙B/Al interactions (see Figure 1). To follow the drug loading process, CM, B12N12, and AlB11N12 structures were fully optimized at Minnesota 2006 with the double Hartree–Fock exchange function (M06-2X) [37] along with the 6-311+G** basis set. Based on the optimized structures, electrostatic potential analysis (ESP) was conducted to clarify the electron-rich and -deficient sites over the molecular surface of the investigated systems. To acquire pictorial descriptions, molecular electrostatic potential (MEP) maps were created using electron density envelopes of 0.002 au [30]. Furthermore, using ESP, the numerical description was obtained by executing and extracting surface electrostatic potential extrema (Vs,min/Vs,max) with the help of Multiwfn 3.7 software [38].
Upon CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes, adsorption (Eads) and interaction (Eint) energies were calculated, and the counterpoise correction method was considered to abolish the basis set superposition error (BSSE) as follows:
E ads   = E CM · · · B 12 N 12 / · · · AlB 11 N 12 E CM + E B 12 N 12 / AlB 11 N 12 + E BSSE
E int   = E CM · · · B 12 N 12 / · · · AlB 11 N 12 E CM   in   complex + E B 12 N 12 / AlB 11 N 12 in   complex + E BSSE
where E CM · · · B 12 N 12 / · · · AlB 11 N 12 , E CM , and E B 12 N 12 / AlB 11 N 12 represent energies of the complex, the isolated CM drug, and the isolated B12N12/AlB11N12 nanocarrier, respectively. E CM   in   complex and E B 12 N 12 / AlB 11 N 12 in   complex are the energies of the CM drug and the B12N12/AlB11N12 nanocarrier based on their respective coordinates in the optimized CM∙∙∙B12N12/∙∙∙AlB11N12 complexes.
To unveil the physical forces that controlled the adsorption process, symmetry-adapted perturbation theory (SAPT) analysis was executed with the help of the PSI4 package [34]. Using SAPT analysis, total adsorption energies could be portioned into four physical components, namely, electrostatic (Eelst), exchange (Eexch), induction (Eind), and dispersion (Edisp) forces. Within SAPT analysis, the SAPT0 level of truncation was applied, and Total SAPT0 energies were calculated as described in the following equations [39]:
E SAPT 0 = E elst + E exch + E ind + E disp
where:
E elst = E elst 10
E exch = E exch 10
E ind = E indresp 20 + E exch indresp 20 +   δ E HFresp 2
E disp = E disp 20 + E exch disp 20
The calculations of the quantum theory of atoms in molecules (QTAIM) in addition to the noncovalent interaction (NCI) index were also performed. Using QTAIM analysis, bond critical points (BCPs) and bond paths (BPs) were induced. Topological features, including total energy density (Hb), Laplacian (∇2ρb), electron density (ρb), kinetic electron density (Gb), local potential electron energy density (Vb), and negative ratio of kinetic and potential electron energy density (−Gb/Vb), were also calculated. Three-dimensional NCI diagrams were generated and visualized using (λ2)ρ with values from –0.035 to 0.020 au and represented by colors ranging from blue to red, respectively. QTAIM and NCI analyses were achieved with the help of Multiwfn 3.7 [38] and pictorially represented using the Visual Molecular Dynamics (VMD) program [40].
To elucidate the electronic parameters, the frontier molecular orbitals (FMOs) theory was invoked. Within the context of FMOs, the electron density distribution of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) were plotted before and after adsorption. In addition, energies of HOMO (EHOMO) and LUMO (ELUMO) were computed. Based on EHOMO and ELUMO values, the Fermi level (EFL) and LUMO–HOMO energy gap (Egap) were calculated by utilizing Equations (8) and (9), respectively.
E FL = E HOMO + E LUMO E HOMO 2
E gap = E LUMO E HOMO
Various electronic properties, including ionization potential (IP), electron affinity (EA), chemical potential (μ), global hardness (η), global softness (S), electrophilicity index (ω), and work function (Φ), were computed for CM, B12N12, and AlB11N12 molecules before and after adsorption, as follows:
I P = E HOMO
E A = E LUMO
η = E LUMO E HOMO 2
μ = E LUMO + E HOMO   2
s = 1 η
ω = μ 2 2 η
Φ = V eL + E FL
where VeL(+∞) is the vacuum-level electrostatic potential that is assumed to be ≈ 0. In parallel, to provide further evidence of the attractive nature of pure and Al-doped (B12N12 and AlB11N12) nanocarriers toward CM adsorption, electrical conductivity was elucidated utilizing the following equation:
σ   α   Exp E gap kT
where σ refers to electrical conductivity, Egap is the energy gap, k is Boltzmann’s constant, and T characterizes temperature. The density of states (DOS) plots were generated using GaussSum software [41]. To explicitly treat the effect of water as a solvent, the polarizable continuum model (PCM) method was applied [42,43]. For the optimized complexes, the solvation ( Δ E solv ) energy was computed as the difference between the total energies in the water and gas phases according to Equation (18). The adsorption energies ( E ads solvent ) in the water phase were also assessed.
Δ E solv = E solvent E g a s
For a more quantitative view of favorability, the thermodynamic parameters including changes in Gibbs free energy (ΔG), enthalpy (ΔH), and entropy (ΔS) were calculated for the studied complexes by applying frequency calculations [44]. The change in thermodynamic parameters was presented as the following equation:
Δ M = M CM · · · B 12 N 12 / · · · AlB 11 N 12 M CM + M B 12 N 12 / AlB 11 N 12 + E BSSE
where ΔM represents the quantity of ΔG, ΔH, and ΔS. Furthermore, M CM · · · B 12 N 12 / · · · AlB 11 N 12 , MCM, and M B 12 N 12 / AlB 11 N 12 introduce the G/H/S parameters of the optimized complexes, the CM drug, and B12N12/AlB11N12 nanocarriers, respectively. In addition, an insightful perspective on the desorption process was gained through calculating recovery time for all considered complexes, as illustrated in the following equation:
t = v 1 e x p Δ G / K T
where ν 1 addresses the attempt frequency of 10–18 s−1. K defines Boltzmann’s constant with a value of 0.00199 kcal/mol.K. T refers to temperature with a value of 310.15 K. All the employed DFT calculations were executed with the Gaussian 09 package [45] using the M06-2X method with the 6-311+G** basis set.

4. Conclusions

The adsorption process of the Chlormethine (CM) drug over the surfaces of the pure and Al-doped boron nitride (B12N12 and AlB11N12) nanocarriers was studied in-depth using various quantum mechanical calculations. From ESP analysis, the electrophilic and nucleophilic natures were affirmed for the studied nanocarriers and the drug, respectively. Moreover, the Vs,max value of Al over the surface of the Al-doped boron nitride (AlB11N12) nanocarrier was somewhat higher than B in the pure nanocarrier. The adsorption energy of the CM∙∙∙AlB11N12 complex within configuration A had the highest negative value, up to –52.40 kcal/mol. Upon SAPT results, electrostatic forces were deemed the predominant force, followed by induction. Furthermore, changes in electronic parameters and global indices of reactivity indicated the favorable contributions of the Al doping process to delivering CM. Delicately, thermodynamic parameters elucidated a spontaneous and exothermic nature for all considered complexes by negative ΔG and ΔH values, respectively. Negative solvation energy values highlighted the further preferentiality of the occurrence of the adsorption process in the water phase more than that in the gas phase. The overarching conclusions from the obtained results affirm the suitability of B12N12 and AlB11N12 nanocarriers in the adsorption process of CM, as well as the potent effect of the Al doping process on their features.

Author Contributions

Conceptualization, M.A.A.I.; methodology, A.-s.S.M.R. and A.M.A.M.; software, M.A.A.I., L.A.M. and M.E.S.S.; validation, A.-s.S.M.R. and N.A.M.M.; formal analysis, A.-s.S.M.R., A.M.A.M. and N.A.M.M.; investigation, A.-s.S.M.R., A.M.A.M. and N.A.M.M.; resources, M.A.A.I., A.M.S. and T.H.A.H.; data curation, A.-s.S.M.R. and A.M.A.M.; writing—original draft, A.-s.S.M.R. and A.M.A.M.; writing—review and editing, M.A.A.I., L.A.M., A.M.S., P.A.S., M.E.S.S., T.H.A.H. and N.A.M.M.; visualization, A.-s.S.M.R. and A.M.A.M.; supervision, M.A.A.I. and L.A.M.; project administration, M.A.A.I. and L.A.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Acknowledgments

Ahmed M. Shawky would like to thank the Deanship of Scientific Research at Umm Al-Qura University for supporting this work by Grant no. 22UQU4331174DSR19. The computational work was completed with resources provided by the Science and Technology Development Fund (STDF), Egypt, grant no. 5480 and 7972 (Granted to Mahmoud A. A. Ibrahim).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mias, S.; Sudor, J.; Camon, H. PNIPAM: A thermo-activated nano-material for use in optical devices. Microsyst. Technol. 2007, 14, 691–695. [Google Scholar] [CrossRef]
  2. Planeix, J.M.; Coustel, N.; Coq, B.; Brotons, V.; Kumbhar, P.S.; Dutartre, R.; Geneste, P.; Bernier, P.; Ajayan, P.M. Application of carbon nanotubes as supports in heterogeneous catalysis. J. Am. Chem. Soc. 1994, 116, 7935–7936. [Google Scholar] [CrossRef]
  3. Varghese, S.S.; Lonkar, S.; Singh, K.K.; Swaminathan, S.; Abdala, A. Recent advances in graphene based gas sensors. Sens. Actuators B Chem. 2015, 218, 160–183. [Google Scholar] [CrossRef]
  4. Ohta, T.; Hashida, Y.; Yamashita, F.; Hashida, M. Development of novel drug and gene delivery carriers composed of single-walled carbon nanotubes and designed peptides with pegylation. J. Pharm. Sci. 2016, 105, 2815–2824. [Google Scholar] [CrossRef] [PubMed]
  5. Tiwari, P.M.; Vig, K.; Dennis, V.A.; Singh, S.R. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1, 31–63. [Google Scholar] [CrossRef]
  6. El-Mageed, H.R.A.; Mustafa, F.M.; Abdel-Latif, M.K. Boron nitride nanoclusters, nanoparticles and nanotubes as a drug carrier for isoniazid anti-tuberculosis drug, computational chemistry approaches. J. Biomol. Struct. Dyn. 2022, 40, 226–235. [Google Scholar] [CrossRef]
  7. Ciofani, G.; Danti, S.; Genchi, G.G.; Mazzolai, B.; Mattoli, V. Boron nitride nanotubes: Biocompatibility and potential spill-over in nanomedicine. Small 2013, 9, 1672–1685. [Google Scholar] [CrossRef] [PubMed]
  8. Ferreira, T.H.; Silva, P.R.O.; Santos, R.G.; Sousa, E.M.B. A novel synthesis route to produce boron nitride nanotubes for bioapplications. J. Biomater. Nanobiotechnol. 2011, 2, 426–434. [Google Scholar] [CrossRef]
  9. Oku, T.; Narita, I.; Koi, N.; Nishiwaki, A.; Suganuma, K.; Inoue, M.; Hiraga, K.; Matsuda, T.; Hirabayashi, M.; Tokoro, H.; et al. Boron nitride nanocage clusters, nanotubes, nanohorns, nanoparticles, and nanocapsules. In B-C-N Nanotubes and Related Nanostructures; Springer: New York, NY, USA, 2009; pp. 149–194. [Google Scholar]
  10. Oku, T.; Kuno, M.; Kitahara, H.; Narita, I. Formation, atomic structures and properties of boron nitride and carbon nanocage fullerene materials. Int. J. Inorg. Mater. 2001, 3, 597–612. [Google Scholar] [CrossRef]
  11. Jensen, F.; Toftlund, H. Structure and stability of C24 and B12N12 isomers. Chem. Phys. Lett. 1993, 201, 89–96. [Google Scholar] [CrossRef]
  12. Soltani, A.; Sousaraei, A.; Javan, M.B.; Eskandari, M.; Balakheyli, H. Electronic and optical properties of 5-AVA-functionalized BN nanoclusters: A DFT study. New J. Chem. 2016, 40, 7018–7026. [Google Scholar] [CrossRef]
  13. Khalili, A.; Baei, M.T.; Ghaboos, S.H.H. Improvement of antioxidative activity of apigenin by B12N12 nanocluster: Antioxidative mechanism analysis. Chemistryselect 2020, 5, 1829–1836. [Google Scholar] [CrossRef]
  14. Oku, T.; Nishiwaki, A.; Narita, I. Formation and atomic structure of B12N12 nanocage clusters studied by mass spectrometry and cluster calculation. Sci. Technol. Adv. Mater. 2004, 5, 635–638. [Google Scholar] [CrossRef]
  15. Bahrami, A.; Seidi, S.; Baheri, T.; Aghamohammadi, M. A first-principles study on the adsorption behavior of amphetamine on pristine, P- and Al-doped B12N12 nano-cages. Superlattice. Microst. 2013, 64, 265–273. [Google Scholar] [CrossRef]
  16. Golipour-Chobar, E.; Salimi, F.; Rajaei, G.E. Boron nitride nanocluster as a carrier for lomustine anticancer drug delivery: DFT and thermodynamics studies. Monatsh. Chem. 2020, 151, 309–318. [Google Scholar] [CrossRef]
  17. Liao, Z.Y.; Song, G.L.; Yang, Z.L.; Ren, H.S. Adsorption and desorption behaviors of hydroxyurea drug on delivery systems of B12N12 fullerene and its Al-, Si- and P-dopings from theoretical perspective. Mol. Phys. 2021, 119, e1921296. [Google Scholar] [CrossRef]
  18. Kang, D.; Yu, X.; Ge, M.; Xiao, F.; Xu, H. Novel Al-doped carbon nanotubes with adsorption and coagulation promotion for organic pollutant removal. J. Environ. Sci. 2017, 54, 1–12. [Google Scholar] [CrossRef] [PubMed]
  19. Jalali Sarvestani, M.R.; Doroudi, Z.; Ahmadi, R. Picric acid adsorption on the surface of pristine and Al-doped boron nitride nanocluster: A comprehensive theoretical study. Russ. J. Phys. Chem. B 2022, 16, 185–196. [Google Scholar] [CrossRef]
  20. Ghafur Rauf, H.; Majedi, S.; Abdulkareem Mahmood, E.; Sofi, M. Adsorption behavior of the Al- and Ga-doped B12N12 nanocages on COn (n = 1, 2) and HnX (n = 2, 3 and X = O, N): A comparative study. Chem. Rev. Lett. 2019, 2, 140–150. [Google Scholar] [CrossRef]
  21. Oishi, A.A.; Dhali, P.; Das, A.; Mondal, S.; Rad, A.S.; Hasan, M.M. Study of the adsorption of chloropicrin on pure and Ga and Al doped B12N12: A comprehensive DFT and QTAIM investigation. Mol. Simulat. 2022, 48, 776–788. [Google Scholar] [CrossRef]
  22. Zhu, H.; Zhao, C.F.; Cai, Q.H.; Fu, X.M.; Sheykhahmad, F.R. Adsorption behavior of 5-aminosalicylic acid drug on the B12N12, AlB11N12 and GaB11N12 nanoclusters: A comparative DFT study. Inorg. Chem. Commun. 2020, 114, 107808. [Google Scholar] [CrossRef]
  23. Piya, A.A.; Shamim, S.U.D.; Uddin, M.N.; Munny, K.N.; Alam, A.; Hossain, M.K.; Ahmed, F. Adsorption behavior of cisplatin anticancer drug on the pristine, Al- and Ga-doped BN nanosheets: A comparative DFT study. Comput. Theor. Chem. 2021, 1200, 113241. [Google Scholar] [CrossRef]
  24. Lessin, S.R.; Duvic, M.; Guitart, J.; Pandya, A.G.; Strober, B.E.; Olsen, E.A.; Hull, C.M.; Knobler, E.H.; Rook, A.H.; Kim, E.J.; et al. Topical chemotherapy in cutaneous T-cell lymphoma: Positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. JAMA Dermatol. 2013, 149, 25–32. [Google Scholar] [CrossRef] [PubMed]
  25. Lindahl, L.M.; Fenger-Gron, M.; Iversen, L. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis. J. Eur. Acad. Dermatol. Venereol. 2013, 27, 163–168. [Google Scholar] [CrossRef]
  26. Bunn, P.A., Jr.; Hoffman, S.J.; Norris, D.; Golitz, L.E.; Aeling, J.L. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome). Ann. Intern. Med. 1994, 121, 592–602. [Google Scholar] [CrossRef]
  27. Rakib Hossain, M.; Mehade Hasan, M.; Ud Daula Shamim, S.; Ferdous, T.; Abul Hossain, M.; Ahmed, F. First-principles study of the adsorption of chlormethine anticancer drug on C24, B12N12 and B12C6N6 nanocages. Comput. Theor. Chem. 2021, 1197, 113156. [Google Scholar] [CrossRef]
  28. Hossain, M.R.; Hasan, M.M.; Nishat, M.; Noor-E-Ashrafi; Ahmed, F.; Ferdous, T.; Abul Hossain, M. DFT and QTAIM investigations of the adsorption of chlormethine anticancer drug on the exterior surface of pristine and transition metal functionalized boron nitride fullerene. J. Mol. Liq. 2021, 323, 114627. [Google Scholar] [CrossRef]
  29. Zhang, J.; Lu, T. Efficient evaluation of electrostatic potential with computerized optimized code. Phys. Chem. Chem. Phys. 2021, 23, 20323–20328. [Google Scholar] [CrossRef]
  30. Ibrahim, M.A.A. Molecular mechanical perspective on halogen bonding. J. Mol. Model. 2012, 18, 4625–4638. [Google Scholar] [CrossRef]
  31. Shakerzadeh, E.; Khodayar, E.; Noorizadeh, S. Theoretical assessment of phosgene adsorption behavior onto pristine, Al- and Ga-doped B12N12 and B16N16 nanoclusters. Comp. Mater. Sci. 2016, 118, 155–171. [Google Scholar] [CrossRef]
  32. Abdolahi, N.; Aghaei, M.; Soltani, A.; Azmoodeh, Z.; Balakheyli, H.; Heidari, F. Adsorption of Celecoxib on B12N12 fullerene: Spectroscopic and DFT/TD-DFT study. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2018, 204, 348–353. [Google Scholar] [CrossRef] [PubMed]
  33. Sheikhi, M.; Kaviani, S.; Azarakhshi, F.; Shahab, S. Superalkali X3O (X = Li, Na, K) doped B12N12 nano-cages as a new drug delivery platform for chlormethine: A DFT approach. Comput. Theor. Chem. 2022, 1212, 113722. [Google Scholar] [CrossRef]
  34. Parrish, R.M.; Burns, L.A.; Smith, D.G.A.; Simmonett, A.C.; DePrince, A.E., III; Hohenstein, E.G.; Bozkaya, U.; Sokolov, A.Y.; Di Remigio, R.; Richard, R.M.; et al. Psi4 1.1: An open-source electronic structure program emphasizing automation, advanced libraries, and interoperability. J. Chem. Theory Comput. 2017, 13, 3185–3197. [Google Scholar] [CrossRef] [PubMed]
  35. Bader, R.F.W. Atoms in molecules. Acc. Chem. Res. 1985, 18, 9–15. [Google Scholar] [CrossRef]
  36. Hasan, M.M.; Das, A.C.; Hossain, M.R.; Hossain, M.K.; Hossain, M.A.; Neher, B.; Ahmed, F. The computational quantum mechanical investigation of the functionalized boron nitride nanocage as the smart carriers for favipiravir drug delivery: A DFT and QTAIM analysis. J. Biomol. Struct. Dyn. 2021, 1–17. [Google Scholar] [CrossRef]
  37. Zhao, Y.; Truhlar, D.G. Exploring the limit of accuracy of the global hybrid meta density functional for main-group thermochemistry, kinetics, and noncovalent interactions. J. Chem. Theory Comput. 2008, 4, 1849–1868. [Google Scholar] [CrossRef]
  38. Lu, T.; Chen, F. Multiwfn: A multifunctional wavefunction analyzer. J. Comput. Chem. 2012, 33, 580–592. [Google Scholar] [CrossRef]
  39. Parker, T.M.; Burns, L.A.; Parrish, R.M.; Ryno, A.G.; Sherrill, C.D. Levels of symmetry adapted perturbation theory (SAPT). I. Efficiency and performance for interaction energies. J. Chem. Phys. 2014, 140, 094106. [Google Scholar] [CrossRef]
  40. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33–38. [Google Scholar] [CrossRef]
  41. O’Boyle, N.M.; Tenderholt, A.L.; Langner, K.M. cclib: A library for package-independent computational chemistry algorithms. J. Comput. Chem. 2008, 29, 839–845. [Google Scholar] [CrossRef]
  42. Tomasi, J.; Mennucci, B.; Cammi, R. Quantum mechanical continuum solvation models. Chem. Rev. 2005, 105, 2999–3093. [Google Scholar] [CrossRef] [PubMed]
  43. Parlak, C.; Alver, O. A density functional theory investigation on amantadine drug interaction with pristine and B, Al, Si, Ga, Ge doped C60 fullerenes. Chem. Phys. Lett. 2017, 678, 85–90. [Google Scholar] [CrossRef]
  44. Ghasemi, A.S.; Taghartapeh, M.R.; Soltani, A.; Mahon, P.J. Adsorption behavior of metformin drug on boron nitride fullerenes: Thermodynamics and DFT studies. J. Mol. Liq. 2019, 275, 955–967. [Google Scholar] [CrossRef]
  45. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09; Revision E01; Gaussian Inc.: Wallingford, CT, USA, 2009. [Google Scholar]
Figure 1. Pictorial representation for the adsorption process of the Chlormethine (CM) anti-cancer drug over pure and aluminum (Al)-doped boron nitride (B12N12 and AlB11N12) nanocarriers through configurations A and B.
Figure 1. Pictorial representation for the adsorption process of the Chlormethine (CM) anti-cancer drug over pure and aluminum (Al)-doped boron nitride (B12N12 and AlB11N12) nanocarriers through configurations A and B.
Pharmaceuticals 15 01181 g001
Figure 2. Optimized structures and molecular electrostatic potential (MEP) maps supplemented with electrostatic potential extrema (Vs,min/Vs,max, in kcal/mol) of CM, B12N12, and AlB11N12. The color scale changes from red (−0.01) to blue (+0.01) au.
Figure 2. Optimized structures and molecular electrostatic potential (MEP) maps supplemented with electrostatic potential extrema (Vs,min/Vs,max, in kcal/mol) of CM, B12N12, and AlB11N12. The color scale changes from red (−0.01) to blue (+0.01) au.
Pharmaceuticals 15 01181 g002
Figure 3. Optimized structures of CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes within configurations A and B (at M06-2X/6-311+G** level of theory) along with molecular electrostatic potential (MEP) maps. MEP maps are plotted using electron density envelopes of 0.002 au. The color scale varies from −0.01 (red) to +0.01 (blue) au. Intermolecular distances (d) within the optimized complexes are given in Å.
Figure 3. Optimized structures of CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes within configurations A and B (at M06-2X/6-311+G** level of theory) along with molecular electrostatic potential (MEP) maps. MEP maps are plotted using electron density envelopes of 0.002 au. The color scale varies from −0.01 (red) to +0.01 (blue) au. Intermolecular distances (d) within the optimized complexes are given in Å.
Pharmaceuticals 15 01181 g003
Figure 4. Bar chart presenting the physical components (i.e., electrostatic (Eelst), induction (Eind), dispersion (Edisp), and exchange (Eexch)) of the total SAPT0 energies for the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes in configurations A and B.
Figure 4. Bar chart presenting the physical components (i.e., electrostatic (Eelst), induction (Eind), dispersion (Edisp), and exchange (Eexch)) of the total SAPT0 energies for the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes in configurations A and B.
Pharmaceuticals 15 01181 g004
Figure 5. Visualized QTAIM and 3D NCI diagrams of the optimized CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes in configurations A and B. In QTAIM diagrams, red dots represent the location of BCPs and BPs. Three-dimensional NCI isosurfaces are graphed with a reduced density gradient value of 0.50 au and colored from blue to red according to sign (λ2)ρ ranging from −rangi (blue) to 0.020 (red) au.
Figure 5. Visualized QTAIM and 3D NCI diagrams of the optimized CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes in configurations A and B. In QTAIM diagrams, red dots represent the location of BCPs and BPs. Three-dimensional NCI isosurfaces are graphed with a reduced density gradient value of 0.50 au and colored from blue to red according to sign (λ2)ρ ranging from −rangi (blue) to 0.020 (red) au.
Pharmaceuticals 15 01181 g005
Figure 6. Diagrams of HOMO and LUMO distributions of CM, B12N12, and AlB11N12 systems.
Figure 6. Diagrams of HOMO and LUMO distributions of CM, B12N12, and AlB11N12 systems.
Pharmaceuticals 15 01181 g006
Figure 7. Diagrams of HOMO and LUMO distributions of the optimized CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configurations A and B.
Figure 7. Diagrams of HOMO and LUMO distributions of the optimized CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configurations A and B.
Pharmaceuticals 15 01181 g007
Figure 8. Density of states (DOS) plots for the B12N12 and AlB11N12 nanocarriers before and after the adsorption process of CM within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configurations A and B.
Figure 8. Density of states (DOS) plots for the B12N12 and AlB11N12 nanocarriers before and after the adsorption process of CM within the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes within configurations A and B.
Pharmaceuticals 15 01181 g008
Table 1. Interaction energy (Eint, kcal/mol) of CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes and adsorption energy (Eads, kcal/mol) within configurations A and B. Intermolecular distances (d) are given in Å.
Table 1. Interaction energy (Eint, kcal/mol) of CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes and adsorption energy (Eads, kcal/mol) within configurations A and B. Intermolecular distances (d) are given in Å.
ComplexConfigurationdEintEads
CM∙∙∙B12N12A1.64−59.55–32.45
B2.82−5.70–5.15
CM∙∙∙AlB11N12A1.97−59.68–52.40
B2.32−31.73–28.15
Table 2. Total energy density (Hb), Laplacian (∇2ρb), electron density (ρb), kinetic electron density (Gb), local potential electron energy density (Vb), and negative ratio of kinetic and potential electron energy density (−Gb/Vb) of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes. All parameters are given in au.
Table 2. Total energy density (Hb), Laplacian (∇2ρb), electron density (ρb), kinetic electron density (Gb), local potential electron energy density (Vb), and negative ratio of kinetic and potential electron energy density (−Gb/Vb) of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes. All parameters are given in au.
ComplexConfigurationHb2ρbρbGbVb−Gb/Vb
CM∙∙∙B12N12A–0.08960.24140.12090.1499–0.23950.6259
B0.00070.03870.01450.0090–0.00831.0842
CM∙∙∙AlB11N12A–0.00460.35810.06550.0942–0.09880.9530
B–0.00580.16330.04280.0466–0.05240.8896
Table 3. The highest occupied molecular orbital (EHOMO), Fermi level (EFL), and the lowest unoccupied molecular orbital (ELUMO), as well as the energy gap (Egap) of optimized CM, B12N12, and AlB11N12 before and after adsorption process. All values are given in eV.
Table 3. The highest occupied molecular orbital (EHOMO), Fermi level (EFL), and the lowest unoccupied molecular orbital (ELUMO), as well as the energy gap (Egap) of optimized CM, B12N12, and AlB11N12 before and after adsorption process. All values are given in eV.
Drug/Nanocarrier/ComplexConfigurationEHOMO
(eV)
EFL
(eV)
ELUMO
(eV)
Egap
(eV)
CM –8.28–3.940.208.48
B12N12 –9.54–5.12–0.359.19
AlB11N12 –9.10–7.05–2.506.60
CM∙∙∙B12N12A–8.92–4.93–0.478.45
B–8.30–4.51–0.367.94
CM∙∙∙AlB11N12A–8.55–4.96–0.687.87
B–8.66–5.12–0.797.87
Table 4. Global indices of reactivity, including ionization potential (IP), electron affinity (EA), chemical potential (μ), global hardness (η), global softness (S), electrophilicity index (ω), and work function (Φ) calculated parameters for CM, B12N12, and AlB11N12 systems before and after adsorption.
Table 4. Global indices of reactivity, including ionization potential (IP), electron affinity (EA), chemical potential (μ), global hardness (η), global softness (S), electrophilicity index (ω), and work function (Φ) calculated parameters for CM, B12N12, and AlB11N12 systems before and after adsorption.
Drug/Nanocarrier/ComplexConfigurationIP
(eV)
EA
(eV)
μ
(eV)
η (eV)S
(eV−1)
ω
(eV)
Φ
(eV)
CM 8.28–0.20–4.044.240.241.923.94
B12N12 9.540.35–4.944.600.222.665.12
AlB11N12 9.102.50–5.803.300.305.107.05
CM∙∙∙B12N12A8.920.47–4.704.220.242.614.93
B8.300.36–4.333.970.252.364.51
CM∙∙∙ AlB11N12A8.550.68–4.623.930.252.714.96
B8.660.79–4.723.930.252.845.12
Table 5. Adsorption ( E ads solvent ) and solvation (ΔEsolv) energies for the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes in the water phase. All energies are calculated in kcal/mol.
Table 5. Adsorption ( E ads solvent ) and solvation (ΔEsolv) energies for the CM∙∙∙B12N12 and ∙∙∙AlB11N12 optimized complexes in the water phase. All energies are calculated in kcal/mol.
ComplexConfiguration
E ads solvent ( kcal / mol )
ΔEsolv a
(kcal/mol)
CM∙∙∙B12N12A–34.22–10.52
B–4.06–7.65
CM∙∙∙AlB11N12A–53.50–15.81
B–27.17–13.72
a  Δ E solv = E solvent E g a s .
Table 6. Thermodynamic parameters, i.e., Gibbs free energy (ΔG), enthalpy change (ΔH), and entropy change (ΔS), of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes computed in kcal/mol.
Table 6. Thermodynamic parameters, i.e., Gibbs free energy (ΔG), enthalpy change (ΔH), and entropy change (ΔS), of the CM∙∙∙B12N12 and ∙∙∙AlB11N12 complexes computed in kcal/mol.
ComplexConfigurationΔGΔHΔS
CM∙∙∙B12N12A–14.72–29.94–0.05
B–5.77–3.97–0.03
CM∙∙∙AlB11N12A–37.15–50.14–0.04
B–15.71–26.79–0.04
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ibrahim, M.A.A.; Rady, A.-s.S.M.; Mandarawe, A.M.A.; Mohamed, L.A.; Shawky, A.M.; Hasanin, T.H.A.; Sidhom, P.A.; Soliman, M.E.S.; Moussa, N.A.M. Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study. Pharmaceuticals 2022, 15, 1181. https://doi.org/10.3390/ph15101181

AMA Style

Ibrahim MAA, Rady A-sSM, Mandarawe AMA, Mohamed LA, Shawky AM, Hasanin THA, Sidhom PA, Soliman MES, Moussa NAM. Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study. Pharmaceuticals. 2022; 15(10):1181. https://doi.org/10.3390/ph15101181

Chicago/Turabian Style

Ibrahim, Mahmoud A. A., Al-shimaa S. M. Rady, Asmaa M. A. Mandarawe, Lamiaa A. Mohamed, Ahmed M. Shawky, Tamer H. A. Hasanin, Peter A. Sidhom, Mahmoud E. S. Soliman, and Nayra A. M. Moussa. 2022. "Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study" Pharmaceuticals 15, no. 10: 1181. https://doi.org/10.3390/ph15101181

APA Style

Ibrahim, M. A. A., Rady, A. -s. S. M., Mandarawe, A. M. A., Mohamed, L. A., Shawky, A. M., Hasanin, T. H. A., Sidhom, P. A., Soliman, M. E. S., & Moussa, N. A. M. (2022). Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study. Pharmaceuticals, 15(10), 1181. https://doi.org/10.3390/ph15101181

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop